2022 American Transplant Congress

TOPIC: Clinical Science » Liver » 56 - Liver: Hepatocellular Carcinoma and Other Malignancies

A Intention-to-Treat Analysis of 881 Consecutively Waitlisted Patients to Develop a Survival Benefit Model for Hepatocellular Carcinoma Liver Transplant Candidates
B. V. Tran¹, W. Lapisatepun¹, W. Dumronggittigule¹, D. Markovic², Y. Lee¹, F. Kaldas¹, D. Farmer¹, R. Busuttil¹, V. Agopian¹
An International Multi-Institutional Comparison of Liver Transplantation for Hepatocellular Carcinoma: United States, United Kingdom, and Canada
T. Ivanics¹, D. Wallace², M. P. Claasen³, M. Patel⁴, W. Jassem⁵, K. Menon⁵, A. Suddle⁵, N. Heaton⁵, N. Mehta⁶, J. van der Meulen², G. Sapisochin³
Characterizing Outcomes of Patients with Colorectal Liver Metastases (CRLM) Undergoing Liver Transplantation (LT) Evaluation
E. Takoushian¹, E. Brandon¹, B. Samstein², K. Halazun²
Clinical Efficacy of Adjuvant Immunotherapy for Liver Transplant Recipients with Exceeding Japan Criteria of Hepatocellular Carcinoma Using Donor Liver Derived Natural Killer Cells
M. Ohira¹, Y. Imaoka², K. Sato³, K. Imaoka¹, N. Tanimine¹, H. Tahara¹, K. Ide¹, T. Kobayashi¹, Y. Tanaka¹, A. G. Tzakis⁴, S. Nishida⁵, H. Ohdan¹
Degree of Pre-Liver Transplant Immune Dysfunction Correlates with Post-Transplant Cancer Recurrence
G. S. Prakash¹, G. G. Panayotova¹, S. Simonishvili¹, Y. Qin¹, L. Jin¹, T. Ayorinde¹, L. J. Minze², F. Paterno¹, L. Brown¹, A. Amin¹, D. Liu¹, R. Ghobrial², J. V. Guarrera¹, K. E. Lunsford¹
Differentially Methylated Genes Predict Post-Transplant Relapse of Unresectable Hepatoblastoma
M. Ningappa¹, M. Muarya², C. Ashokkumar¹, H. Hakonarson³, S. Subramaniam⁴, R. Sindhi¹
Disparities in Liver Transplantation in Patients with HCC Diagnosis
C. Warren¹, A. Zarrinpar²
Everolimus in Liver Transplantation for Diffuse, Unresectable Neuroendocrine Tumor
J. M. Vanatta¹, R. A. Helmick², C. Eymard², N. Nezakatgoo², P. Horton², J. P. Kothadia², S. P. Nair², J. D. Eason²
Exploring Individual Optimal Immunosuppression Management According to the Oncological Risk in Liver Transplanted Patients with Hepatocellular Carcinoma
K. Sasakik¹, S. Kimura², D. Soma³, K. Tomiyama⁴, M. Matthew⁴, M. Fruscione², C. Kubal³, D. Kwon⁵
Higher Hepatocellular Carcinoma Tumor Burden Score is Associated with Grater Liver Transplant Survival Benefit
H. Liu¹, W. Zhang², M. Di³, H. Lee⁴, R. Cruz¹, X. Wang², C. Kaltenmeier¹, A. Thompson¹, D. Reddy¹, E. Ashwat¹, M. D'Alesio¹, S. Lebowitz¹, S. Tohme¹, D. Geller¹, A. Tevar¹, C. Hughes¹, A. Humar¹, J. Behari⁵, R. Bataller⁵, S. Hariharan⁵, M. Molinari¹